“Hybrid Red Blood Cell–Tumor Cell Membrane-Coated Nanoparticles for Cancer Therapy: Biological Principles, Therapeutic Applications, and Translational Challenges” (2026) World Journal of Current Medical and Pharmaceutical Research, 8(2), pp. 88–100. doi:10.37022/wjcmpr.v8i2.403.